SEI Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-44,302
Closed -$1.6M 2719
2023
Q2
$1.6M Sell
44,302
-5,912
-12% -$244K ﹤0.01% 1715
2023
Q1
$1.87M Buy
+50,214
New +$2.26M ﹤0.01% 1650
2022
Q4
Sell
-54,669
Closed -$3.82M 2713
2022
Q3
$3.82M Buy
54,669
+874
+2% +$64.7K 0.01% 1219
2022
Q2
$3.61M Buy
53,795
+48,496
+915% +$3.08M 0.01% 1258
2022
Q1
$436K Sell
5,299
-50
-0.9% -$5.11K ﹤0.01% 2146
2021
Q4
$785K Buy
5,349
+12
+0.2% +$1.86K ﹤0.01% 1939
2021
Q3
$944K Sell
5,337
-2,049
-28% -$330K ﹤0.01% 1804
2021
Q2
$1.19M Sell
7,386
-4,520
-38% -$726K ﹤0.01% 1741
2021
Q1
$2.28M Buy
11,906
+2,596
+28% +$514K 0.01% 1392
2020
Q4
$2.04M Sell
9,310
-5,462
-37% -$1.18M 0.01% 1378
2020
Q3
$2.45M Buy
14,772
+5,491
+59% +$751K 0.01% 1195
2020
Q2
$1.06M Sell
9,281
-860
-8% -$83.4K ﹤0.01% 1539
2020
Q1
$780K Sell
10,141
-822
-7% -$73.7K ﹤0.01% 1570
2019
Q4
$1.41M Buy
10,963
+4
+0% +$386 ﹤0.01% 1491
2019
Q3
$854K Sell
10,959
-1,236
-10% -$116K ﹤0.01% 1668
2019
Q2
$1.26M Sell
12,195
-8,369
-41% -$652K ﹤0.01% 1524
2019
Q1
$1.51M Buy
+20,564
New +$1.4M 0.01% 1423
2018
Q3
Sell
-20,154
Closed -$994K 3552
2018
Q2
$994K Buy
+20,154
New +$761K ﹤0.01% 1589

Other funds holding MRTX

SEI Investments's MRTX Position: Q3 2023 in Review

SEI Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 44,302 shares — an estimated $1.6M sold.

SEI Investments first reported a position in MRTX in Q2 2018 and held it in 18 quarters. The position peaked at $3.82M in Q3 2022. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.

  • SEI Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • SEI Investments sold 44,302 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.6M.
  • SEI Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • SEI Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $3.82M in Q3 2022.
  • 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.

Based on SEI Investments's 13F filing for Q3 2023, filed 14 Nov 2023.